Eastman Acquires Spain’s 3F Feed & Food

US specialty materials company Eastman Chemical has acquired 3F Feed & Food, a Spanish company specializing in the development of additives for animal feed and human food. Financial details of the transaction were not disclosed. The newly acquired business will become part of Eastman’s Additives & Functional Products segment.

3F Feed & Food is headquartered in Madrid and operates a manufacturing facility in Aviles. Its portfolio includes preservatives and acidifiers of feed and water; binders and granulation improvers; probiotics and prebiotics; silage additives; and food preservatives.

Eastman said the addition of 3F Feed & Food will strengthen and support the ongoing global growth of its animal nutrition business. It added that with global sustainability trends creating the need for higher farm productivity, reduced emissions and a shift away from antibiotic growth promoters and other materials of concern in diets, 3F's portfolio of specialized organic acid derivatives and phytogenics are “well positioned and proven to help customers adapt and to deliver improved animal productivity and resiliency.”

Sandeep Bangaru, Eastman’s general manager, animal nutrition, commented: “With 3F, Eastman will extend our specialty product portfolio in animal nutrition gut health for swine and poultry and increase our application development capabilities, both of which will enable us to accelerate growth of key markets and customers.”

Author: Elaine Burridge, Freelance Journalist

Eastman Chemical has acquired 3F Feed & Food, a Spanish specialist in additives...
Eastman Chemical has acquired 3F Feed & Food, a Spanish specialist in additives for animal feed and human food. 3F Feed & Food is headquartered in Madrid and operates a manufacturing facility in Aviles. It will become part of Eastman’s Additives & Functional Products segment. (c) Eastman

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.